A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases. SpringWorks is the brainchild of Lara Sullivan, a former Pfizer R&D strategy executive who gained Pfizer's ...

high-cost treatments that target a patient's genetic source or cell to cure or significantly alter the course of a disease. Pfizer on Wednesday said its experimental gene therapy for a rare ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

A total of three cases of Creutzfeldt-Jakob disease, a rare and incurable brain condition, have been detected in Hood River ...

Paid and presented by Pfizer. To everyone except his family ... are helping the healthcare community recognise and diagnose rare diseases and support patients more confidently.

That study is looking at the gene therapy, called fordadistrogene movaparvovec, to treat Duchenne muscular dystrophy, a rare and fatal muscle-wasting disease that primarily affects boys.

and rare diseases. It also develops and manufactures vaccines. Pfizer collaborated with German biotech company BioNTech SE (BNTX) to develop one of the world's most widely used mRNA-based vaccines ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for autoimmune diseases. The collaboration between Pfizer and Pioneering Medicines, ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to ...